Hoque, Kazi Mirajul, Vazhaikkurichi M. Rajendran, and Henry J. Binder. Zinc inhibits cAMP-stimulated Cl secretion via basolateral K-channel blockade in rat ileum. Am J Physiol Gastrointest Liver Physiol 288: G956 -G963, 2005. First published December 23, 2004 doi:10.1152/ajpgi.00441.2004.-Zn, an essential micronutrient and second most abundant trace element in cell and tissues, reduces stool output when administered to children with acute diarrhea. The mechanism by which Zn improves diarrhea is not known but could result from stimulating Na absorption and/or inhibiting anion secretion. The aim of this study was to investigate the direct effect of Zn on intestinal epithelial ion absorption and secretion. Rat ileum was partially stripped of serosal and muscle layers, and the mucosa was mounted in lucite chambers. Potential difference and short-circuit current were measured by conventional current-voltage clamp method.
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86 Rb efflux; 86 Rb uptake; K-channel inhibitors DIARRHEAL DISEASES REMAIN a major public health problem especially in children in developing countries throughout the world, with ϳ1.5 billion episodes per year. It is estimated that diarrheal diseases cause 1.5-2.5 million deaths each year among children younger than five years old and contribute substantially to malnutrition in surviving children (9, 22, 30) . After the introduction of oral rehydration solution (ORS) more than 30 years ago, the treatment of acute diarrhea has dramatically changed and ORS use has become widespread. ORS corrects dehydration and metabolic acidosis due to fluid and bicarbonate losses and reduces mortality. However, ORS does not substantially decrease stool output nor does it decrease the duration of episodes or their consequences such as malnutrition (33, 51) . As a result, improved or "super ORSs" as well as other approaches for enhancing treatment of acute diarrhea have continually been sought and evaluated. Recently, Zn supplementation to ORS has been shown to reduce substantially the duration and severity of diarrhea in children with both acute and persistent diarrhea (6, 7, 36, 38, 50) . The initial suggestion of the mechanism by which Zn was effective to improve diarrhea was that Zn administration corrected an underlying micronutrient deficiency that had contributed, in some way, to the child's diarrhea. However, the demonstration that Zn is effective in both Zn-deficient and nondeficient children (O. Fontaine, personal communication) suggested that the action of Zn might be related to a direct effect on intestinal absorptive and/or secretory transport processes.
Diarrheal disorders are almost always associated with changes in fluid and electrolyte movement so that a decrease in absorption and/or an increase in secretion have been invariably found in most diarrheal disorders. An effective antidiarrheal agent should either enhance fluid and electrolyte absorption and/or reduce fluid and electrolyte secretion. ORS is effective by virtue of its stimulation of small intestinal fluid absorption as a result of glucose stimulation of Na absorption via SGLT1. Over the past 25 years, multiple detailed studies of active Cl secretion, which has long been considered the driving force for fluid secretion, have been performed. The present model of Cl secretion includes the coordinated action of an apical membrane Cl channel (e.g., CFTR) and on the basolateral membrane Na-K-ATPase, Na-K-2Cl cotransport (NKCC), and one or more K channels (3, 24) . As the effect of Zn on intestinal ion transport has not been previously evaluated, the aim of this present study was to investigate the effect of Zn on Na absorption and Cl secretion in rat ileal mucosa to determine whether Zn enhances Na absorption and/or inhibits Cl secretion. These experiments demonstrated that Zn selectively inhibited cAMP-induced Cl secretion, whereas additional studies established that Zn was a potential inhibitor of cAMP-activated K channels on basolateral membrane of ileal epithelial cells.
MATERIALS AND METHODS

Preparation of Epithelia
Nonfasting male Sprague-Dawley rats (200 -250 g) were used in all experiments. Rats were anesthetized and killed by inhalation of ether. All the experimental protocol performed in this study had been approved by the Institutional Animal Care and Use Committee of Yale University.
The distal ileum removed from anesthetized rats was placed in HCO 3 Ϫ -free Ringer solution that contained (in mM) 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 4 glutamine, pH 7.4. The ileum was partially stripped of serosal and muscle layers, and the mucosa was mounted in lucite chambers and bathed at 37°C on both sides with HCO 3 Ϫ -free Ringer solution, which was continually circulated with a gas lift oxygenated with 100% O2. An HCO 3 Ϫ /CO2 buffer system was not used due to Zn insolubility in such a solution. Zn was used as the chloride salt (ZnCl 2), which was prepared in HCO 3 Ϫ -free Ringer just before its addition to the chamber. Potential difference was measured; tissues were studied under voltage-clamp conditions (DVC 1000 dual voltage clamp, WPI, Sarasota, FL), and conductance was calculated.
After tissues were mounted, there was a 30-min equilibration period before the addition of one or more agents to either the mucosal or serosal sides of the tissue. The increase in short-circuit current (I sc) induced by 10 mM mucosal glucose represented Na absorption, whereas the increase in I sc induced by 10 M forskolin (FSK), 1 mM 8-BrcAMP, or 200 M carbachol represented Cl secretion. The viability of epithelia was examined by the mucosal addition of 10 mM glucose at the end of each experiment.
Isolation of Intestinal Crypt Enterocytes
Epithelial cells were isolated from rat ileum according to previously described methods (44, 49) with modification. Briefly, the distal portion of intestine was removed and washed free of fecal material with ice-cold 0.9% NaCl containing 1 mM DTT. The intestine was then filled with a solution containing (in mM) 96 NaCl, 27 sodium citrate, 1.5 KCl, 0.8 KH 2PO4, 5.6 K2HPO4, and 4 glutamine, pH 7.3. After being emptied, the intestinal lumen was again filled with this solution and incubated for 15 min at 37°C. After drainage of the fluid, the intestine was then filled with a buffer containing (in mM) 115 NaCl, 25 NaHCO 3, 2.4 K2HPO4, 0.4 KH2PO4, 4 glutamine, 0.5 EDTA, and 0.5 DTT. The intestine was drained, and after being filled with this solution a second time, it was incubated for 6 min with frequent finger tapping to facilitate cell dispersion with collection of the contents. Five additional cell fractions were collected and passed through two to three layers of cheese cloth. The cell fractions were centrifuged at 1,000 g for 5 min, and the pellet was then washed with Hanks' balanced salt solution (HBSS; Invitrogen, Carlsbad, California) and suspended in HBSS at room temperature (pH 7.4). Crypt cell-enriched fractions isolated in fractions 4 -6 were combined and used for the uptake and efflux studies. Cell numbers were determined with a hemocytometer, and a viability test was performed with trypan blue exclusion technique in which the dye was incorporated only into the dead cells, whereas the viable cells excluded trypan blue. 86 Rb efflux in isolated crypt enterocytes. According to the previously described methods (12, 20, 28) , these isolated cells were suspended in HBSS containing 2 mM RbCl and then loaded with 2 Ci/ml 86 Rb by incubation at 37°C for 40 -60 min, by which time the incorporation of 86 Rb into cells had achieved a steady-state concentration (data not shown); 85 Ϯ 5% cells were viable. Ouabain (0.5 mM) and bumetanide (0.2 mM) were added for the final 15-20 min to inhibit 86 Rb movement via Na-K-ATPase and NKCC, respectively. Cells were then incubated at room temperature. Efflux was initiated by transferring 100 l cell aliquot of 4 ϫ 10 6 cells/ml cell suspension to the flux media [in mM: 135 NaCl, 1 CaCl2, 1 Na2HPO4, 2 Na2SO4, 15 HEPES, 1 MgCl2, and 4 glutamine (pH 7.4)] that also contained 0.5 mM ouabain and 0.2 mM bumetanide. The cells were further incubated for 10 -15 min with or without Zn or with one or more K-channel blockers, as indicated in the figure legends. Either 1 mM 8-BrcAMP or 200 M carbachol were added to the cells for 3-5 min after which efflux was determined for 5 min. Efflux was stopped by transferring 86 Rb-labeled cells to the 0.45-m filter paper that was then washed with 5 ml of ice-cold 100 mM MgCl2 plus 10 mM HEPES-Tris, pH 7.4. Each filter was subsequently excised and placed in a vial; 3.0 ml of Opti-Fluor (Packard Bioscience, Meriden, CT) were added, and radioactivity was measured by a liquid scintillation system (Beckman LS1801). 86 Rb efflux was expressed as a percentage of remaining cell 86 Rb content compared with its initial cell 86 Rb content. Thus cAMP-stimulated, bumetanide-insensitive, and ouabain-insensitive 86 Rb efflux was considered to represent 86 Rb movement via K channels.
Radionuclide Efflux and Influx Studies
86 Rb uptake studies in isolated cells. Uptake studies were performed according to methods previously described (13, 29, 31) . Isolated rat enterocytes were washed with HBSS (pH 7.4) and were equilibrated for 20 -30 min in a low-Cl isotonic medium. The low-Cl isotonic medium contained (in mM) 135 Na-gluconate, 5 K-gluconate, 1 CaCl 2, 1 MgCl2, 1 NaH2PO4, 2 Na2SO4, 15 HEPES, and 4 glutamine (pH 7.4). Cells were then incubated for 15-20 min in the same solution in presence of ouabain (0.5 mM), an Na-K-ATPase inhibitor, and Ba (3 mM), a K-channel blocker, with or without Zn (1 mM). 8-BrcAMP was added for an additional 5-min incubation. Uptake was initiated by transferring 100-l cell aliquots (4 ϫ 10 6 cell/ml cell suspension) to the low-Cl isotonic medium containing 2 Ci/ml 86 Rb. Influx was terminated after 3 min by transferring the suspension of whole cells to the 0.45-m filter paper, which was rapidly washed three times with ice-cold 100 mM MgCl 2 and 10 mM HEPES-Tris (pH 7.4). 86 Rb content was measured. cAMP-stimulated, ouabain-insensitive, Ba-insensitive, and bumetanide-sensitive uptake was considered to represent NKCC activity. 
Statistics
Results are presented as means Ϯ SE. Statistical analyses were performed using paired and unpaired t-test by the statistical software Origin (version 6.0). In the 86 Rb efflux and uptake studies ANOVA with post hoc Bonferroni's test was used to assess statistical significance. P Ͻ 0.05 was considered significant.
RESULTS
Effect of Zn on glucose-stimulated I sc
To determine whether Zn affected glucose-stimulated Na absorption via SGLT1, cotransport experiments were performed in which 1 mM Zn was added either to the mucosal or to the serosal solutions 10 min before the addition of 10 mM glucose to the mucosal solution. The increase in I sc following the addition of mucosal glucose reflects an increase in Na absorption and was identical in the tissues pretreated with mucosal Zn compared with the control group. Serosal addition of 1 mM Zn also did not have any effect on glucose-stimulated I sc (Fig. 1 ). In addition, the addition of 1 mM Zn either to the mucosal or to the serosal solution did not significantly alter basal I sc over 20 min (data not shown). These observations suggest that mucosal pretreatment of Zn did not have any stimulatory effect on glucose-stimulated Na absorption.
Effect of Zn on Forskolin-Stimulated Cl Secretion
To assess whether Zn modified cAMP-stimulated Cl secretion, experiments were performed to evaluate the effect of Zn on FSK-stimulated I sc . FSK activates adenylate cyclase resulting in an increase in mucosal cAMP levels and stimulation of active Cl secretion in many tissues (41) . Similar to earlier observations (15, 44) , serosal addition of 10 M FSK resulted in an immediate and sustained increase in I sc (⌬I sc : 54.6 Ϯ 1.1
A/cm
2 ) that reached a peak in 5-10 min following the addition of FSK and remained near maximal levels throughout the experimental period (40 min). The subsequent addition of 1 mM Zn to the serosal solution resulted in a prompt decrease in I sc (⌬I sc : 46.9 Ϯ 5.4 vs. 2.4 Ϯ 0.9 A/cm 2 ; P Ͻ 0.001; Fig.  2A ). In contrast, mucosal addition of Zn had no effect on FSK-stimulated I sc . Transepithelial conductance (G t ) was also monitored before and after mucosal and serosal addition of Zn to examine whether Zn also affected G t . Basal G t was 10.9 Ϯ 1.3 mS/cm 2 , and G t after the addition of mucosal or serosal Zn was similar (12.1 Ϯ 2.5 and 10.8 Ϯ 1.0 mS/cm 2 , respectively). In a separate series of experiments, the serosal addition of FSK to tissues that had been pretreated with 1 mM Zn did not significantly increase I sc . The addition of 1 mM Zn to the mucosal bathing solution did not inhibit the increase in I sc observed following FSK addition, indicating that serosal but not mucosal addition of Zn reduced FSK-stimulated I sc (Fig. 2B) .
Effect of Zn on 8-BrcAMP-Stimulated Cl Secretion
To distinguish between the effects of Zn at one or more sites of the cAMP-stimulated Cl secretory process vs. an inhibitory effect on adenylate cyclase, experiments were performed in which the effect of Zn on 8-BrcAMP-stimulated I sc was determined. The addition of 1 mM 8-BrcAMP to the serosal solution caused an immediate and sustained increase in I sc . This sustained increase of I sc stimulated by 8-BrcAMP was also reversed by serosal addition of 1 mM Zn. In contrast, mucosal addition of 1 mM Zn did not alter 8-BrcAMP-stimulated I sc (Fig. 3) .
The inhibition of cAMP-stimulated I sc by Zn was also evaluated by experiments in which Zn was added before the stimulation of Cl secretion. The change in I sc following the addition of 8-BrcAMP in tissues that had been pretreated with Zn was also significantly reduced compared with that of control tissues (7.7 Ϯ 3.1 vs. 53.5 Ϯ 7.1 A/cm 2 ; P Ͻ 0.01). In contrast, the mucosal addition of Zn did not alter the subsequent increase in I sc produced by 8-BrcAMP (56.2 Ϯ 5.7 vs. 53.5 Ϯ 7.1 A/cm 2 ; not significantly different). All subsequent experiments that assessed the effect of Zn on cAMPmediated changes in I sc were thus performed with 1 mM 8-BrcAMP.
To establish the half-maximal inhibitory concentration (IC 50 ) of Zn on 8-BrcAMP-stimulated Cl secretion, experiments were performed in which varying concentrations of Zn were added before stimulation of I sc by 8-BrcAMP. The inhibition of 8-BrcAMP-stimulated I sc by Zn was dose dependent (Fig. 4) , with maximal inhibition observed with 1 mM Zn. IC 50 for inhibition of 8-BrcAMP-induced I sc was derived from a nonlinear fit of the dose-response data according to the Boltzman equation (42) . The determined IC 50 value was 0.43 Ϯ 0.04 mM Zn. These observations indicate that serosal Zn prevents cAMP stimulation of active Cl secretion, possibly by inhibiting one or more basolateral transport sites that are critical for cAMP-mediated active Cl secretion but not by affecting either adenydate cyclase or apical membrane CFTR. 
Effect of Zn on NKCC
The results presented in Figs. 2 and 3 indicate that Zn inhibited cAMP-induced I sc by an effect on a basolateral but not an apical membrane transport mechanism. Basolateral transport mechanisms associated with cAMP-induced Cl secretion include NKCC, Na-K-ATPase, and K channels. Basolateral NKCC represents the major ion-entry pathway required for transepithelial Cl secretion, and its activity has been determined by the bumetanide-sensitive component of 86 Rb uptake, as previously reported (19, 27 ). 8-BrcAMP-induced 86 Rb uptake (as a surrogate of K) was determined in the presence of 0.5 mM ouabain and 3 mM Ba. Figure 5 shows that neither bumetanide-sensitive nor -insensitive 86 Rb fluxes were affected by Zn in the presence of 8-BrcAMP.
Effect of Zn on K Channels
To determine whether Zn acts as a K-channel blocker, 86 Rb efflux experiments were performed using enterocytes isolated from rat ileum. To inhibit cAMP-stimulated 86 Rb efflux via non-K-channel pathways, e.g., NKCC and Na-K-ATPase, these experiments were performed in the presence of bumetanide and ouabain, respectively. Figure 6A demonstrates the effect of Zn and Ba on 8-BrcAMP-induced 86 Rb efflux. The sensitivity of 8-BrcAMP-induced 86 Rb efflux to Zn was potent (65%) and greater than that of 3 mM Ba (52.2%). The combined effect of Zn plus Ba on 86 Rb efflux was also determined. Inhibition of 86 Rb efflux by the presence of both Zn plus Ba was significantly less than that affected by Zn alone. Inhibition of 86 Rb efflux by Ba did not significantly differ from that of both Zn and Ba together (Fig. 6A) . The effect of 293B, a specific inhibitor of cAMP-activated K channels (25), on 86 Rb efflux was also examined. Figure 6B demonstrates that 293B alone and Zn alone both inhibited cAMP stimulation by ϳ70%. cAMP-activated 86 Rb efflux was also inhibited by ϳ70% in the presence of 293B and Zn together, suggesting that Zn was blocking the same K channel as does 293B.
To establish that Zn inhibits 8-BrcAMP-induced Cl secretion by blocking K channels, IC 50 for Zn on 8-BrcAMPstimulated 86 Rb efflux was also determined (Fig. 7) . Increasing Zn concentrations progressively inhibit 8-BrcAMP-stimulated 86 Rb efflux with an IC 50 for Zn of 0.53 Ϯ 0.06 mM Zn (Fig. 7) . These observations suggest that Zn inhibits cAMP-stimulated Cl secretion by blocking basolateral membrane K channels that provide a driving force for Cl secretion.
Effect of Barium on 8-BrcAMP-Stimulated Cl Secretion
Previous studies (2, 21, 26, 34) have shown that two pharmacologically distinct K channels are responsible for providing the driving force for transepithelial Cl secretion in a number of 86 Rb uptake in rat ileal enterocytes. Isolated enterocytes were preincubated in the presence of either bumetanide or Zn, as indicated. All cells were incubated with 0.5 mM ouabain and 3 mM Ba to inhibit Rb uptake via Na-K-ATPase and K channels, respectively, and, as indicated, with bumetanide and/or Zn. Uptake was then initiated as described in MATERIALS AND METHODS. Values are means Ϯ SE (n ϭ 3). *P Ͻ 0.001, significantly different from control group. epithelia and T84 cells, one that is sensitive to inhibition by Ba and associated with increased mucosal cAMP levels and a second Ba-insensitive pathway that is activated by elevated intracellular Ca. Therefore, experiments were designed to establish whether Cl secretion induced by 8-BrcAMP was also inhibited by Ba. The addition of 3 mM Ba to the serosal bath significantly inhibited the increase in I sc induced by 8-BrcAMP (Fig. 8) . Because mucosal Ba has also been shown to inhibit aldosterone-induced K secretion in rat distal colon (45) , the effect of Ba added to the mucosal bath on 8-BrcAMP-induced Cl secretion was also examined. In these present studies, both serosal and mucosal Ba also inhibited Cl secretion (Fig. 8) .
Studies with Carbachol
To establish the specificity of the effect of Zn on cAMPstimulated I sc , experiments were designed to assess the effect of Zn on the increase in I sc induced by agonists that stimulate Cl secretion as a result of an increase in intracellular Ca. In these experiments the addition of 200 M carbachol to the serosal bath resulted in a prompt increase in I sc , similar to that previously observed in T84 cells and rabbit distal colon (34, 35) . In contrast to that observed with 8-BrcAMP, the effect of carbachol on I sc was not altered in tissue preincubated with either 1 mM serosal Zn or 3 mM serosal Ba (Fig. 9A) . Therefore, 86 Rb efflux was also determined in carbacholstimulated cells to evaluate whether Zn would modify calciummediated efflux. Figure 9B shows that carbachol-stimulated 86 Rb efflux was not affected either by Zn or by Ba. In contrast, clotrimazole, a known inhibitor of Ca-mediated Cl secretion, significantly inhibited 86 Rb efflux induced by carbachol. These observations establish that Zn selectively inhibits basolateral K channels that are activated by cAMP but not by Ca.
DISCUSSION
The primary treatment of acute diarrhea especially in children has been oral rehydration solution. In controlled studies, oral rehydration therapy is very effective in correcting dehydration and reducing mortality (48) . However, oral rehydration solution neither dramatically decreases stool volume nor reduces the duration of the disease course (47) . Therefore, several different approaches have been evaluated to improve Ba inhibited 86 Rb efflux, whereas simultaneous presence of both Zn and Ba did not result in a great inhibition of 86 Rb efflux. B: individual presence of Zn-and Ba-inhibited 86 Rb efflux was measured in isolated enterocytes, as described in MATERIALS AND METHODS. Ouabain (0.5 mM) and 0.2 mM bumetanide were added to all cells to inhibit efflux via Na-KATPase and Na-K-2Cl cotransport (NKCC), respectively. Basal efflux was determined in the absence of 8-BrcAMP and subtracted from all experimental conditions. Results are expressed as means Ϯ SE (n ϭ 5). *P Ͻ 0.05 compared with control group. Fig. 7 . Kinetics of Zn inhibition of 8-BrcAMP-stimulated 86 Rb efflux in isolated rat enterocytes. 86 Rb efflux was measured in isolated enterocytes, as described in MATERIALS AND METHODS. Ouabain (0.5 mM) and 0.2 mM bumetanide were added to all cells to inhibit efflux via Na-K-ATPase and NKCC, respectively. The basal efflux was determined in the absence of 8-BrcAMP and subtracted from all experimental conditions. Results are expressed as means Ϯ SE of 4 different experiments. the therapy of acute diarrhea by modifying oral rehydration solution with the primary aim to reduce stool fluid losses and shorten the duration of diarrhea. Most efforts have focused on the enhancement of small intestinal fluid and Na absorption with the use of meal-or cereal-based and/or hypo-osmolar solutions (46) . Recently, the use of amylase-resistant starch added to ORS was evaluated based on the premise that increased delivery of nonabsorbed carbohydrate to the colon will result in enhanced production of short-chain fatty acids, which, in turn, will stimulate Na and fluid absorption (8, 32) .
Several prior studies have demonstrated the efficacy of Zn in the treatment of acute diarrhea (6, 7, 36, 38, 50) but have not provided any insight into the mechanism by which Zn improves fluid and electrolyte transport. Dietary deficiency of some micronutrients has been shown to increase the susceptibility of infants and children to gastrointestinal infection and to adversely affect gastrointestinal tract structure and function (5, 38) . In particular, Zn deficiency can be associated with chronic diarrhea (1) . It has been reported that in Zn deficiency-associated diarrhea, Zn may help maintain the integrity of the gut mucosa to reduce or prevent fluid loss (4) . However, studies of Zn treatment of acute and persistent diarrhea did not demonstrate that nutritional status affected the beneficial effects of Zn, suggesting that Zn was effective in the treatment of diarrhea in both Zn-deficient and -replete children (O. Fontaine, personal communication). To date, there are no reports of the pharmacological and/or pathophysiological effect of Zn on intestinal ion transport, although in one recent study (11) , the effect of both theophylline, a phosphodiesterase inhibitor, and 5-HT, a serotonin agonist, on I sc across ileal mucosa was reduced in piglets fed a relatively high Zn diet compared with that in piglets fed a "normal" diet. These observations are consistent with the present experimental results.
Symptomatic antidiarrheal therapy should either enhance fluid and Na absorption and/or inhibit fluid and anion secretion (10) . For example, oral rehydration solution is effective by virtue of its stimulation of Na absorption via SGLT1, whereas the effect of clonidine on diabetic diarrhea may be a result of an increase in electroneutral Na-Cl absorption (40) . Although glucocorticoids are used in the treatment of ulcerative colitis for their anti-inflammatory actions, steroids also increase Na absorption via ENaC (17, 37) . Studies in normal volunteers indicate that the primary effect of loperamide is to prolong transit time with a resulting increase in the efficiency of absorption (39) . In contrast, other therapeutic agents are effective by virtue of their ability to inhibit anion secretion (14) .
The present experiments systematically examined the effect of Zn on electrogenic absorptive and secretory processes in the rat ileum to assess whether Zn enhanced Na absorption and/or inhibited Cl secretion. These results established that mucosal pretreatment of isolated rat ileal tissue with Zn did not have any stimulatory effect on glucose-stimulated Na absorption. The failure of basolateral addition of Zn to modify glucosestimulated I sc also indicated that Zn did not induce an increase in glucose-stimulated I sc as a result of increasing Na-K-ATPase, and the population of K channels inhibited by Zn is not active during glucose-stimulated increase in I sc . The effect of Zn on electroneutral Na-Cl absorption was not examined in these present studies.
In contrast to the absence of an effect of Zn on glucosestimulated Na absorption, these present results demonstrated that Zn inhibited cAMP-stimulated Cl secretion. Because Zn inhibited both FSK-and cAMP-stimulated Cl secretion, the action of Zn on cAMP-stimulated Cl secretion is at a site distal to the generation of cAMP and is not due to its inhibition of adenylate cyclase. A model of cAMP stimulation of Cl secretion has been well established in experiments with both intact intestinal tissue and T84 cells during the past two decades. cAMP-stimulated Cl secretion requires the coordinated interaction of apical membrane CFTR with Na-K-ATPase, NKCC, and K channel on the basolateral membrane (3, 24) . These present studies in which mucosal Zn did not alter cAMPstimulated Cl secretion suggest that Zn did not inhibit effect on CFTR. It is unlikely that Zn inhibited Na-K-ATPase, because serosal Zn did not inhibit glucose-stimulated I sc . Furthermore, Zn did not affect NKCC activity, which was estimated by the bumetanide-sensitive component of 86 Rb uptake (Fig. 5) . Furthermore, it is unlikely that Zn affects NKCC function, because NKCC is critical to both cAMP-and Ca-mediated Cl secretion and Zn inhibited cAMP-mediated but not Ca-mediated Cl secretion.
Several experiments provided compelling evidence that Zn inhibited cAMP-stimulated Cl secretion as a result of its inhibition of cAMP-mediated basolateral membrane K channels. First, Zn blocked cAMP-induced 86 Rb efflux from isolated ileal enterocytes (Figs. 5-7) . In intact tissue, Zn inhibited 8-BrcAMP-stimulated Cl secretion with an identical IC 50 (0.46 mM; Fig. 4) to that which inhibited 8-BrcAMP-stimulated 86 Rb efflux in isolated cells (0.53 mM; Fig. 7) . Second, Ba, a known K-channel blocker, also inhibited cAMP-induced Cl secretion, and Ba prevented the inhibition of 86 Rb efflux by Zn (Fig. 6) . Third, carbachol, an agonist that also induces Cl 86 Rb efflux in isolated rat ileal entrocytes. 86 Rb efflux was measured in isolated enterocytes, as described in MATERIALS AND METHODS. Ouabain (0.5 mM) and 0.2 mM bumetanide were added to all cells to inhibit efflux via Na-K-ATPase and NKCC, respectively. Values are means Ϯ SE of 4 different experiments. *P Ͻ 0.01, significantly different from control group. secretion via an increase in intracellular Ca, increased 86 Rb efflux, which was not inhibited by Zn (Fig. 9) . Fourth, Zn did not affect either CFTR, Na-K-ATPase function, or NKCC activity. These several observations suggest that Zn selectively acts to block cAMP-mediated but not Ca-dependent basolateral K channels.
The effects of Zn and Ba on 8-BrcAMP-stimulated Cl secretion were not identical. Although both mucosal and serosal Ba affected 8-BrcAMP Cl secretion, only serosal Zn inhibited 8-BrcAMP-stimulated Cl secretion. cAMP induces active K secretion by virtue of its activation of one or more apical membrane K channels. These observations indicate that distinct K channels are activated by cAMP on the apical and basolateral membranes and suggest that the apical membrane K channel is Ba but not Zn sensitive, whereas basolateral K channels are sensitive to both Ba and Zn.
The protocol for the 86 Rb efflux studies required the presence of ouabain to inhibit Rb efflux via the Na pump. Such inhibition can induce cell swelling, resulting in activation of both K channels and K-Cl cotransport. However, it is unlikely that the inhibition of 86 Rb efflux by Zn solely represents inhibition of volume-sensitive K channels; as such, K channels are cAMP independent. In contrast, Zn most likely selectively blocks cAMP-activated K channels, because both Zn and 293B, a specific inhibitor of cAMP-activated channels (49) , appear to block the same K channel (Fig. 6B) .
Future studies are required to delineate the specific basolateral K channel that is inhibited by Zn. Because both cAMPactivated (KCNQ1) and Ca-activated K channels have been identified in basolateral membranes of enterocytes (49 -51) , it is likely that Zn inhibits KCNQ1. The recent demonstration that barium affects the gating of KCNQ1 (17) is consistent with the speculation that Zn acts via KCNQ1, because the present results indicate that barium and Zn block the same K channel (Fig. 6A) . However, the site of the action of Zn must also be established, because Zn may initially enter the cell and bind to the cytosolic side of a basolateral K channel. Prior studies (51) have established that Zn interacts with large-conductance (BK) K channels in neurons. However, these studies demonstrated that Zn prevented the opening of the BK channel. Such an effect differs from the present observations in that Zn reversed the effect of cAMP-stimulated Cl secretion (Fig. 3) .
In conclusion, the data presented in this study provide definitive evidence that in intact tissue and in isolated enterocytes of rat ileum, Zn inhibits cAMP-stimulated Cl secretion by selectively inhibiting a cAMP-activated basolateral K channel. These observations suggest that Zn may be effective in other cAMP-mediated secretory diarrheal disorders and that other K-channel blockers may have the potential for development as anti-diarrheal agents.
